Digital Therapeutics for MCI
A multi-domain intervention aimed at reducing dementia risk and slowing cognitive decline in patients with mild cognitive impairment.
Medical Device Certification
The Ministry of Food and Drug Safety has designated SOPY as an Innovative Medical Device.
Proven to be effective
95% of the experimental group experienced a significant improvement in cognitive function
Current Research Insights
Papers
Development of a digital multidomain lifestyle intervention for mild cognitive impairment: A pilot study on the feasibility and efficacy of cognitive training (2024)
Efficacy of a Mobile-Based Multidomain Intervention to Improve Cognitive Function and Health-Related Outcomes Among Older Korean Adults with Subjective Cognitive Decline (2023)
The effects of a mobile-based multi-domain intervention on cognitive function among older adults (2023)